Invention Grant
- Patent Title: Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
-
Application No.: US17387881Application Date: 2021-07-28
-
Publication No.: US11648245B2Publication Date: 2023-05-16
- Inventor: Hazel Hunt , Tony Johnson , Nicholas Ray , Iain Walters
- Applicant: Corcept Therapeutics, Inc.
- Applicant Address: US CA Menlo Park
- Assignee: Corcept Therapeutics, Inc.
- Current Assignee: Corcept Therapeutics, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Kilpatrick Townsend & Stockton LLP
- The original application number of the division: US14487347 2014.09.16
- Main IPC: A61K31/4745
- IPC: A61K31/4745 ; C07D471/04 ; A61K31/506 ; A61K31/5377 ; A61K31/497 ; C07D498/04 ; A61K31/5383 ; A61K31/56 ; C07D519/00 ; A61K45/06
Abstract:
The present invention provides heteroaryl ketone fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators, including their use for treating amyotrophic lateral sclerosis (ALS).
Public/Granted literature
- US20210369701A1 HETEROARYL-KETONE FUSED AZADECALIN GLUCOCORTICOID RECEPTOR MODULATORS Public/Granted day:2021-12-02
Information query
IPC分类:
